Physicians at La Fe University and Polytechnic Hospital - Valencia presented their early clinical outcome data on the use of Esteya® electronic brachytherapy for the treatment of basal cell carcinoma in a paper in the current issue of Journal of Contemporary Brachytherapy. The ongoing study showed 100 percent complete response and excellent cosmetic outcome in all lesions treated to date with Esteya.
The paper, "Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma," is based on data from an ongoing, prospective clinical study.
The investigators conclude that Esteya electronic brachytherapy is a good treatment alternative for patients who are unsuitable for surgery, in addition to those who have declined surgery, have multiple lesions and for whom electronic brachytherapy might improve cosmetic outcome.
SOURCE Elekta
New PULSAR radiation-therapy strategy achieves better tumor control